A Rare Side Effect of Intravesical Bacillus Calmette-Guérin Therapy: Reactive Arthritis
Approximately 70-80% of bladder cancers are superficial tumors and not muscle invasive. Complete transurethral resection of the bladder tumour (TUR-BT) is the standard approach to these patients. Intravesical treatments such as adriamycin, doxorubicin, epirubicin, mitomycin-c and Bacillus Calmette-G...
Gespeichert in:
| Veröffentlicht in: | Üroonkoloji bülteni 2018-03, Vol.17 (1), p.33-35 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 35 |
|---|---|
| container_issue | 1 |
| container_start_page | 33 |
| container_title | Üroonkoloji bülteni |
| container_volume | 17 |
| creator | Kızılgök, Bahattin İzol, Volkan Erken, Eren Tansuğ, Mustafa Zühtü |
| description | Approximately 70-80% of bladder cancers are superficial tumors and not muscle invasive. Complete transurethral resection of the bladder tumour
(TUR-BT) is the standard approach to these patients. Intravesical treatments such as adriamycin, doxorubicin, epirubicin, mitomycin-c and Bacillus
Calmette-Guérin (BCG) may be performed after TUR-BT in order to prevent further recurrence or progression. BCG is generally used in high-risk
patients and causes local or systemic side effects in less than 5% of patients. Osteoarticular side effects are very rare and usually manifest as joint pain
and arthritis (%0.5-1). In this case report, we present the management of reactive arthritis in a patient treated with intravesical BCG for bladder cancer. |
| doi_str_mv | 10.4274/uob.915 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_ideal</sourceid><recordid>TN_cdi_idealonline_journals_IDEAL_68933</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2117148898</sourcerecordid><originalsourceid>FETCH-LOGICAL-c248t-fc613057adaccb7661253f66407f1c919d10ca67f6f5a57a3608e2f69881cc9e3</originalsourceid><addsrcrecordid>eNpNkMFKAzEURYMoWGrxFwIuXE1NMjNJxt1Y21ooCLWCu5CmLzRlOlOTTKGf5Hf4Y45UqKt3F4d7eQehW0qGGRPZQ9ushgXNL1CP0UwkjAly-S9fo0EIW0IIFZIwyXvoo8QL7QG_uTXgsbVgIm4sntXR6wMEZ3SFn7RxVdUGPNLVDmKEZNp-f3lX4-UGvN4fH_ECtInuALj0ceNddOEGXVldBRj83T56n4yXo5dk_jqdjcp5YlgmY2INpynJhV5rY1aCc8ry1HKeEWGpKWixpsRoLiy3ue6wlBMJzPJCSmpMAWkf3Z169775bCFEtW1aX3eTilEqaCZlITvq_kR1b-qqqStXwxmcPY_LueKySNMzaXwTgger9t7ttD8qStSvY9U5Vp3j9AcPfG3K</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2117148898</pqid></control><display><type>article</type><title>A Rare Side Effect of Intravesical Bacillus Calmette-Guérin Therapy: Reactive Arthritis</title><source>EZB-FREE-00999 freely available EZB journals</source><creator>Kızılgök, Bahattin ; İzol, Volkan ; Erken, Eren ; Tansuğ, Mustafa Zühtü</creator><contributor>Koşan,Murat Tevfik</contributor><creatorcontrib>Kızılgök, Bahattin ; İzol, Volkan ; Erken, Eren ; Tansuğ, Mustafa Zühtü ; Koşan,Murat Tevfik</creatorcontrib><description>Approximately 70-80% of bladder cancers are superficial tumors and not muscle invasive. Complete transurethral resection of the bladder tumour
(TUR-BT) is the standard approach to these patients. Intravesical treatments such as adriamycin, doxorubicin, epirubicin, mitomycin-c and Bacillus
Calmette-Guérin (BCG) may be performed after TUR-BT in order to prevent further recurrence or progression. BCG is generally used in high-risk
patients and causes local or systemic side effects in less than 5% of patients. Osteoarticular side effects are very rare and usually manifest as joint pain
and arthritis (%0.5-1). In this case report, we present the management of reactive arthritis in a patient treated with intravesical BCG for bladder cancer.</description><identifier>ISSN: 2147-2270</identifier><identifier>ISSN: 2147-2122</identifier><identifier>EISSN: 2147-2270</identifier><identifier>DOI: 10.4274/uob.915</identifier><language>eng</language><publisher>Istanbul: Üroonkoloji Derneği</publisher><subject>Arthritis ; Bladder cancer ; Blood tests ; Cancer therapies ; Cytokines ; Immunotherapy ; Laboratories ; NMR ; Nuclear magnetic resonance ; Pain ; Patients ; Rheumatology ; Tıp ; Tumors ; Urinalysis ; Urine ; Urology</subject><ispartof>Üroonkoloji bülteni, 2018-03, Vol.17 (1), p.33-35</ispartof><rights>2018. This work is published under https://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c248t-fc613057adaccb7661253f66407f1c919d10ca67f6f5a57a3608e2f69881cc9e3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><contributor>Koşan,Murat Tevfik</contributor><creatorcontrib>Kızılgök, Bahattin</creatorcontrib><creatorcontrib>İzol, Volkan</creatorcontrib><creatorcontrib>Erken, Eren</creatorcontrib><creatorcontrib>Tansuğ, Mustafa Zühtü</creatorcontrib><title>A Rare Side Effect of Intravesical Bacillus Calmette-Guérin Therapy: Reactive Arthritis</title><title>Üroonkoloji bülteni</title><description>Approximately 70-80% of bladder cancers are superficial tumors and not muscle invasive. Complete transurethral resection of the bladder tumour
(TUR-BT) is the standard approach to these patients. Intravesical treatments such as adriamycin, doxorubicin, epirubicin, mitomycin-c and Bacillus
Calmette-Guérin (BCG) may be performed after TUR-BT in order to prevent further recurrence or progression. BCG is generally used in high-risk
patients and causes local or systemic side effects in less than 5% of patients. Osteoarticular side effects are very rare and usually manifest as joint pain
and arthritis (%0.5-1). In this case report, we present the management of reactive arthritis in a patient treated with intravesical BCG for bladder cancer.</description><subject>Arthritis</subject><subject>Bladder cancer</subject><subject>Blood tests</subject><subject>Cancer therapies</subject><subject>Cytokines</subject><subject>Immunotherapy</subject><subject>Laboratories</subject><subject>NMR</subject><subject>Nuclear magnetic resonance</subject><subject>Pain</subject><subject>Patients</subject><subject>Rheumatology</subject><subject>Tıp</subject><subject>Tumors</subject><subject>Urinalysis</subject><subject>Urine</subject><subject>Urology</subject><issn>2147-2270</issn><issn>2147-2122</issn><issn>2147-2270</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNpNkMFKAzEURYMoWGrxFwIuXE1NMjNJxt1Y21ooCLWCu5CmLzRlOlOTTKGf5Hf4Y45UqKt3F4d7eQehW0qGGRPZQ9ushgXNL1CP0UwkjAly-S9fo0EIW0IIFZIwyXvoo8QL7QG_uTXgsbVgIm4sntXR6wMEZ3SFn7RxVdUGPNLVDmKEZNp-f3lX4-UGvN4fH_ECtInuALj0ceNddOEGXVldBRj83T56n4yXo5dk_jqdjcp5YlgmY2INpynJhV5rY1aCc8ry1HKeEWGpKWixpsRoLiy3ue6wlBMJzPJCSmpMAWkf3Z169775bCFEtW1aX3eTilEqaCZlITvq_kR1b-qqqStXwxmcPY_LueKySNMzaXwTgger9t7ttD8qStSvY9U5Vp3j9AcPfG3K</recordid><startdate>20180301</startdate><enddate>20180301</enddate><creator>Kızılgök, Bahattin</creator><creator>İzol, Volkan</creator><creator>Erken, Eren</creator><creator>Tansuğ, Mustafa Zühtü</creator><general>Üroonkoloji Derneği</general><general>Galenos Publishing House</general><scope>AAYXX</scope><scope>CITATION</scope><scope>IEBAR</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20180301</creationdate><title>A Rare Side Effect of Intravesical Bacillus Calmette-Guérin Therapy: Reactive Arthritis</title><author>Kızılgök, Bahattin ; İzol, Volkan ; Erken, Eren ; Tansuğ, Mustafa Zühtü</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c248t-fc613057adaccb7661253f66407f1c919d10ca67f6f5a57a3608e2f69881cc9e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Arthritis</topic><topic>Bladder cancer</topic><topic>Blood tests</topic><topic>Cancer therapies</topic><topic>Cytokines</topic><topic>Immunotherapy</topic><topic>Laboratories</topic><topic>NMR</topic><topic>Nuclear magnetic resonance</topic><topic>Pain</topic><topic>Patients</topic><topic>Rheumatology</topic><topic>Tıp</topic><topic>Tumors</topic><topic>Urinalysis</topic><topic>Urine</topic><topic>Urology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kızılgök, Bahattin</creatorcontrib><creatorcontrib>İzol, Volkan</creatorcontrib><creatorcontrib>Erken, Eren</creatorcontrib><creatorcontrib>Tansuğ, Mustafa Zühtü</creatorcontrib><collection>CrossRef</collection><collection>Idealonline online kütüphane - Journals</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Üroonkoloji bülteni</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kızılgök, Bahattin</au><au>İzol, Volkan</au><au>Erken, Eren</au><au>Tansuğ, Mustafa Zühtü</au><au>Koşan,Murat Tevfik</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A Rare Side Effect of Intravesical Bacillus Calmette-Guérin Therapy: Reactive Arthritis</atitle><jtitle>Üroonkoloji bülteni</jtitle><date>2018-03-01</date><risdate>2018</risdate><volume>17</volume><issue>1</issue><spage>33</spage><epage>35</epage><pages>33-35</pages><issn>2147-2270</issn><issn>2147-2122</issn><eissn>2147-2270</eissn><abstract>Approximately 70-80% of bladder cancers are superficial tumors and not muscle invasive. Complete transurethral resection of the bladder tumour
(TUR-BT) is the standard approach to these patients. Intravesical treatments such as adriamycin, doxorubicin, epirubicin, mitomycin-c and Bacillus
Calmette-Guérin (BCG) may be performed after TUR-BT in order to prevent further recurrence or progression. BCG is generally used in high-risk
patients and causes local or systemic side effects in less than 5% of patients. Osteoarticular side effects are very rare and usually manifest as joint pain
and arthritis (%0.5-1). In this case report, we present the management of reactive arthritis in a patient treated with intravesical BCG for bladder cancer.</abstract><cop>Istanbul</cop><pub>Üroonkoloji Derneği</pub><doi>10.4274/uob.915</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2147-2270 |
| ispartof | Üroonkoloji bülteni, 2018-03, Vol.17 (1), p.33-35 |
| issn | 2147-2270 2147-2122 2147-2270 |
| language | eng |
| recordid | cdi_idealonline_journals_IDEAL_68933 |
| source | EZB-FREE-00999 freely available EZB journals |
| subjects | Arthritis Bladder cancer Blood tests Cancer therapies Cytokines Immunotherapy Laboratories NMR Nuclear magnetic resonance Pain Patients Rheumatology Tıp Tumors Urinalysis Urine Urology |
| title | A Rare Side Effect of Intravesical Bacillus Calmette-Guérin Therapy: Reactive Arthritis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T18%3A40%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_ideal&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20Rare%20Side%20Effect%20of%20Intravesical%20Bacillus%20Calmette-Gu%C3%A9rin%20Therapy:%20Reactive%20Arthritis&rft.jtitle=%C3%9Croonkoloji%20b%C3%BClteni&rft.au=K%C4%B1z%C4%B1lg%C3%B6k,%20Bahattin&rft.date=2018-03-01&rft.volume=17&rft.issue=1&rft.spage=33&rft.epage=35&rft.pages=33-35&rft.issn=2147-2270&rft.eissn=2147-2270&rft_id=info:doi/10.4274/uob.915&rft_dat=%3Cproquest_ideal%3E2117148898%3C/proquest_ideal%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2117148898&rft_id=info:pmid/&rfr_iscdi=true |